Tech Company Financing Transactions
Javelin Pharmaceuticals Funding Round
On 6/30/2008, Javelin Pharmaceuticals landed $27.6 million in funding from ProQuest Investments and private investors.
Transaction Overview
Company Name
Announced On
6/30/2008
Transaction Type
Venture Equity
Amount
$27,600,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
125 CambridgePark Drive
Cambridge, MA 02140
USA
Cambridge, MA 02140
USA
Phone
Email Address
Overview
Javelin is a specialty pharmaceutical company that applies innovative proprietary delivery technologies to develop new, improved formulations of existing drugs that target unmet and underserved medical needs in the growing pain management market.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Martin Driscoll
Chief Financial Officer
Stephen Tulipano
Chief Medical Officer
Daniel Carr
Vice President
Frederick Pierce
VP - R & D
Eric Lang
Browse more venture capital transactions:
Prev: 6/30/2008: Xceive venture capital transaction
Next: 6/30/2008: Pinnacle Pharmaceuticals venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. All VC database entries reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs